| _version_ |
1860797550863319040
|
| building |
INTELEK Repository
|
| collection |
Online Access
|
| collectionurl |
https://intelek.unisza.edu.my/intelek/pages/search.php?search=!collection407072
|
| date |
2024-08-27 16:58:20
|
| format |
Restricted Document
|
| id |
13203
|
| institution |
UniSZA
|
| internalnotes |
1. WHO. Safety Monitoring of Medicinal Products Guidelines for setting up and running a Pharmacovigilance Centre EQUUS London: Uppsala Monitoring Centre, WHO Collaborating Centre for International Drug Monitoring; 2000 [cited 2015 03/09/2015]. Available from: http://whoumc.org/graphics/24747.pdf. 2. Zed PJ, Abu-Laban RB, Balen RM, et al. Incidence, severity and preventability of medication-related visits to the emergency department: a prospective study. Canadian Medical Association Journal. 2008;178(12):1563-9. 3. Sikdar KC, Alaghehbandan R, MacDonald D, et al. Adverse drug events in adult patients leading to emergency department visits. Annals of Pharmacotherapy. 2010;44(4):641-9. 4. Jayarama N, Shiju K, Prabahakar K. Adverse drug reactions in adults leading to emergency department visits. Int J Pharm Pharm Sci. 2012;4:642-6. 5. Zed PJ. Drug-related visits to the emergency department. Journal of pharmacy practice. 2005;18(5):329-35. 6. Kohn LT, Corrigan JM, Donaldson MS. To err is human:: building a Safer Health System: National Academies Press; 2000. 7. Tipping B, Kalula S, Badri M. The burden and risk factors for adverse drug events in older patients-a prospective crosssectional study: original article. South African Medical Journal. 2006;96(12): 1255-9. 8. MS. D. An Overview of To Err is Human: Re-emphasizing the Message of Patient Safety. Rockville (MD): Agency for Healthcare Research and Quality (US); 2008 [cited 2015. Available from: http://www.ncbi.nlm.nih.gov/books/NB K2673/. 9. Stang AS, Wingert AS, Hartling L, et al. Adverse events related to emergency department care: a systematic review. PloS one. 2013;8(9):e74214. 10. Smyth R, Gargon E, Kirkham J, et al. Adverse drug reactions in children-a systematic review. PloS One. 2012;7(3):e24061. 11. Field TS, Gurwitz JH, Harrold LR, et al. Risk factors for adverse drug events among older adults in the ambulatory setting. Journal of the American Geriatrics Society. 2004;52(8):1349-54. 12. The National Health and Medical Research Council. NHMRC Evidence Hierarchy [cited 2015 12/10/2015]. Available from: https://www.nhmrc.gov.au/_files_nhmr c/file/guidelines/developers/nhmrc_leve ls_grades_evidence_120423.pdf. 13. Chen Y-C, Huang H-H, Fan J-S, et al. Comparing Characteristics of Adverse Drug Events Between Older and Younger Adults Presenting to a Taiwan Emergency Department. Medicine. 2015;94(7):e547. 14. Chang CM, Liu PYY, Yang YHK, et al. Use of the Beers Criteria to Predict Adverse Drug Reactions Among First‐Visit Elderly Outpatients. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2005;25(6):831-8. 15. De Paepe P, Petrovic M, Outtier L, et al. Drug interactions and adverse drug reactions in the older patients admitted to the emergency department. Acta Clinica Belgica. 2013;68(1):15-21. 16. Hafner JW, Belknap SM, Squillante MD, et al. Adverse drug events in emergency department patients. Annals of Emergency medicine. 2002;39(3):258-67. 17. Olivier P, Bertrand L, Tubery M, et al. Hospitalizations because of adverse drug reactions in elderly patients admitted through the emergency department. Drugs & aging. 2009;26(6):475-82. 18. Chen Wu CMB WPW. Incidence and Economic Burden of Adverse Drug Reactions among Elderly Patients in Ontario Emergency Departments A Retrospective Study. Drug safety 2012;9:769-81. 19. Franceschi A, Tuccori M, Bocci G, et al. Drug therapeutic failures in emergency department patients: a university hospital experience. Pharmacological research. 2004;49(1):85-91. 20. Cusack B, Nielson C, Vestal R. Geriatric clinical pharmacology and therapeutics. Avery’s Drug treatment. 4th ed. Auckland, New Zealand: Adis International. 1997:173-223. 21. Drici M-D, Clément N. Is gender a risk factor for adverse drug reactions? Drug safety. 2001;24(8):575-85. 22. Viktil KK, Blix HS, Reikvam A, et al. Comparison of drug-related problems in different patient groups. Annals of Pharmacotherapy. 2004;38(6):942-8. 23. Ramos Linares S DRP, Mesa Fumero J, . Incidence rate of adverse drug effects in a hospital emergency unit and its associated factors. J.Farma. 2010;34(6):271-8. 24. Harduar-Morano L, Simon MR, Watkins S, et al. A population-based epidemiologic study of emergency department visits for anaphylaxis in Florida. Journal of Allergy and Clinical Immunology. 2011;128(3):594-600. 25. Malhotra S, Karan R, Pandhi P, et al. Drug related medical emergencies in the elderly: role of adverse drug reactions and non-compliance. Postgraduate Medical Journal. 2001;77(913):703-7. 26. Svarstad BL, Cleary PD, Mechanic D, et al. Gender differences in the acquisition of prescribed drugs: an epidemiological study. Medical Care. 1987;1089-98. 27. Alomar MJ. Factors affecting the development of adverse drug reactions (Review article). Saudi Pharmaceutical Journal. 2014;22(2):83-94. 28. McDowell SE, Coleman JJ, Ferner R. Systematic review and meta-analysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine. BMJ. 2006;332(7551):1177-81. 29. Egger T, Dormann H, Ahne G, et al. Cytochrome P450 Polymorphisms in Geriatric Patients. Drugs & aging. 2005;22(3):265-72. 30. Meyer UA. Pharmacogenetics and adverse drug reactions. The Lancet. 2000;356(9242):1667-71. 31. Perron BE, Bohnert AS, Monsell SE, et al. Patterns and correlates of drug-related ED visits: results from a national survey. The American Journal of Emergency medicine. 2011;29(7):704-10. 32. Lantz PM, House JS, Lepkowski JM, et al. Socioeconomic factors, health behaviors, and mortality: results from a nationally representative prospective study of US adults. JAMA. 1998;279(21):1703-8. 33. Baena MI, Faus MJ, Fajardo PC, et al. Medicine-related problems resulting in emergency department visits. European Journal of Clinical Pharmacology. 2006;62(5):387-93. 34. Cadieux R. Drug interactions in the elderly. How multiple drug use increases risk exponentially. Postgraduate Medicine. 1989;86(8):179-86. 35. Blix HS, Viktil KK, Moger TA, et al. Drugs with narrow therapeutic index as indicators in the risk management of hospitalised patients. Pharm Pr Granada. 2010;8:50-5. 36. Pedrós C, Quintana B, Rebolledo M, et al. Prevalence, risk factors and main features of adverse drug reactions leading to hospital admission. European Journal of Clinical Pharmacology. 2014;70(3):361-7. 37. Heaton PC, Tundia NL, Luder HR. US emergency departments visits resulting from poor medication adherence: 2005- 07. Journal of the American Pharmacists Association: 2012;53(5):513-9. 38. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly: an update. Archives of Internal Medicine. 1997;157(14):1531-6. 39. Budnitz DS, Lovegrove MC, Shehab N, et al. Emergency hospitalizations for adverse drug events in older Americans. New England Journal of Medicine. 2011;365(21):2002-12. 40. Perrone V, Conti V, Venegoni M, et al. seriousness, preventability, and burden impact of reported adverse drug reactions in lombardy emergency departments: a retrospective 2-year characterization. ClinicoEconomics and Outcomes Research. 2014;6:505. 41. Chang CB, Chen JH, Wen CJ, et al. Potentially inappropriate medications in geriatric outpatients with polypharmacy: application of six sets of published explicit criteria. British Journal of Clinical Pharmacology. 2011;72(3):482-9. 42. Simon SR, Smith DH, Feldstein AC, et al. Computerized prescribing alerts and group academic detailing to reduce the use of potentially inappropriate medications in older people. Journal of the American Geriatrics Society. 2006;54(6):963-8. 43. Chen Y-C, Fan J-S, Chen M-H, et al. Risk factors associated with adverse drug events among older adults in emergency department. European Journal of Internal Medicine. 2014;25(1):49-55. 44. Hohl CM, Yu E, Hunte GS, et al. Clinical decision rules to improve the detection of adverse drug events in emergency department patients. Academic Emergency Medicine. 2012;19(6):640-9. 45. Capuano A, Irpino A, Gallo M, et al. Regional surveillance of emergencydepartment visits for outpatient adverse drug events. European journal of clinical pharmacology. 2009;65(7):721-8. 46. Roulet L, Ballereau F, Hardouin J-B, et al. Assessment of adverse drug event recognition by emergency physicians in a French teaching hospital. Emergency Medicine Journal. 2013;30(1):63-7. 47. Pretorius RW, Gataric G, Swedlund SK, et al. Reducing the risk of adverse drug events in older adults. Am Fam Physician. 2013;87(5):331-6. 48. Rieger K, Scholer A, Arnet I, et al. High prevalence of unknown co-medication in hospitalised patients. European Journal of Clinical Pharmacology. 2004;60(5):363-8. 49. Ventura MT, Laddaga R, Cavallera P, et al. Adverse drug reactions as the cause of emergency department admission: focus on the elderly. Immunopharmacology and immunotoxicology. 2010;32(3):426-9. 50. Kissinger P, Cohen D, Brandon W, et al. Compliance with public sector HIV medical care. Journal of the National Medical Association. 1995;87(1):19. 51. Shea S, Misra D, Ehrlich MH, et al. Correlates of nonadherence to hypertension treatment in an inner-city minority population. American Journal of Public Health. 1992;82(12):1607-12. 52. Chen YC, Fan JS, Hsu TF, et al. Detection of patients presenting with adverse drug events in the emergency department. Internal medicine journal. 2012;42(6):651-7. 53. Segal R, Pilote L. Warfarin interaction with Matricaria chamomilla. Canadian Medical Association Journal. 2006;174(9):1281-2. 54. Nickel CH, Ruedinger JM, Messmer AS, et al. Drug-related emergency department visits by elderly patients presenting with non-specific complaints. Scand J Trauma Resusc Emerg Med. 2013;21(1):15. 55. Castro I, Guardiola JM, Tuneu L, et al. Drug-related visits to the emergency department in a Spanish university hospital. International Journal of Clinical Pharmacy. 2013;35(5):727-35.
|
| originalfilename |
7512-01-FH02-FSK-16-06244.pdf
|
| person |
PAVILION x360
|
| recordtype |
oai_dc
|
| resourceurl |
https://intelek.unisza.edu.my/intelek/pages/view.php?ref=13203
|
| spelling |
13203 https://intelek.unisza.edu.my/intelek/pages/view.php?ref=13203 https://intelek.unisza.edu.my/intelek/pages/search.php?search=!collection407072 Restricted Document Article Journal application/pdf Adobe Acrobat Pro DC 20 Paper Capture Plug-in with ClearScan 13 1.6 PAVILION x360 2024-08-27 16:58:20 7512-01-FH02-FSK-16-06244.pdf UniSZA Private Access Factors Associated With Drug-Related Emergency Department Visit: A Systematic Review Journal of Public Health Medicine Drug-related hospitalization has been identified as a significant contributor to mortality, morbidity and increase in healthcare cost. This systematic review examines the factors associated with drug-related emergency department (ED) visit to better understand the factors, including the common drugs involved and people at high risk of drug-related ED visits. Relevant articles published from January 2000 to September 2015 were identified from PubMed and from a manual search of a reference list of articles. A total of 30 studies were reviewed based on the inclusion criteria. From this review, drug-related ED visit was found to be multifactorial. Many factors such as; old age, female gender, ethnicity, being socially disconnected, low health practice index, polypharmacy, comorbidity, drugs with narrow therapeutic index, drug use in management of chronic illness, drug abuse, drug intoxication, self-medication, presence of chronic illness, long-term care residents, consulting multiple prescribers and pharmacies were found to be associated with drug-related ED visit. The classes of drugs most frequently implicated were cardiovascular agents, central nervous systems (CNS) agents, anticoagulants, antimicrobials, antidiabetics, NSAIDS, antiasthmatics, corticosteroids, chemotherapeutic agents and aphrodisiacs. Preventive measures to improve patient safety should be focused towards the identified factors and the frequently implicated drugs. 16 3 Malaysian Public Health Physicians Association Malaysian Public Health Physicians Association 134-146 1. WHO. Safety Monitoring of Medicinal Products Guidelines for setting up and running a Pharmacovigilance Centre EQUUS London: Uppsala Monitoring Centre, WHO Collaborating Centre for International Drug Monitoring; 2000 [cited 2015 03/09/2015]. Available from: http://whoumc.org/graphics/24747.pdf. 2. Zed PJ, Abu-Laban RB, Balen RM, et al. Incidence, severity and preventability of medication-related visits to the emergency department: a prospective study. Canadian Medical Association Journal. 2008;178(12):1563-9. 3. Sikdar KC, Alaghehbandan R, MacDonald D, et al. Adverse drug events in adult patients leading to emergency department visits. Annals of Pharmacotherapy. 2010;44(4):641-9. 4. Jayarama N, Shiju K, Prabahakar K. Adverse drug reactions in adults leading to emergency department visits. Int J Pharm Pharm Sci. 2012;4:642-6. 5. Zed PJ. Drug-related visits to the emergency department. Journal of pharmacy practice. 2005;18(5):329-35. 6. Kohn LT, Corrigan JM, Donaldson MS. To err is human:: building a Safer Health System: National Academies Press; 2000. 7. Tipping B, Kalula S, Badri M. The burden and risk factors for adverse drug events in older patients-a prospective crosssectional study: original article. South African Medical Journal. 2006;96(12): 1255-9. 8. MS. D. An Overview of To Err is Human: Re-emphasizing the Message of Patient Safety. Rockville (MD): Agency for Healthcare Research and Quality (US); 2008 [cited 2015. Available from: http://www.ncbi.nlm.nih.gov/books/NB K2673/. 9. Stang AS, Wingert AS, Hartling L, et al. Adverse events related to emergency department care: a systematic review. PloS one. 2013;8(9):e74214. 10. Smyth R, Gargon E, Kirkham J, et al. Adverse drug reactions in children-a systematic review. PloS One. 2012;7(3):e24061. 11. Field TS, Gurwitz JH, Harrold LR, et al. Risk factors for adverse drug events among older adults in the ambulatory setting. Journal of the American Geriatrics Society. 2004;52(8):1349-54. 12. The National Health and Medical Research Council. NHMRC Evidence Hierarchy [cited 2015 12/10/2015]. Available from: https://www.nhmrc.gov.au/_files_nhmr c/file/guidelines/developers/nhmrc_leve ls_grades_evidence_120423.pdf. 13. Chen Y-C, Huang H-H, Fan J-S, et al. Comparing Characteristics of Adverse Drug Events Between Older and Younger Adults Presenting to a Taiwan Emergency Department. Medicine. 2015;94(7):e547. 14. Chang CM, Liu PYY, Yang YHK, et al. Use of the Beers Criteria to Predict Adverse Drug Reactions Among First‐Visit Elderly Outpatients. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2005;25(6):831-8. 15. De Paepe P, Petrovic M, Outtier L, et al. Drug interactions and adverse drug reactions in the older patients admitted to the emergency department. Acta Clinica Belgica. 2013;68(1):15-21. 16. Hafner JW, Belknap SM, Squillante MD, et al. Adverse drug events in emergency department patients. Annals of Emergency medicine. 2002;39(3):258-67. 17. Olivier P, Bertrand L, Tubery M, et al. Hospitalizations because of adverse drug reactions in elderly patients admitted through the emergency department. Drugs & aging. 2009;26(6):475-82. 18. Chen Wu CMB WPW. Incidence and Economic Burden of Adverse Drug Reactions among Elderly Patients in Ontario Emergency Departments A Retrospective Study. Drug safety 2012;9:769-81. 19. Franceschi A, Tuccori M, Bocci G, et al. Drug therapeutic failures in emergency department patients: a university hospital experience. Pharmacological research. 2004;49(1):85-91. 20. Cusack B, Nielson C, Vestal R. Geriatric clinical pharmacology and therapeutics. Avery’s Drug treatment. 4th ed. Auckland, New Zealand: Adis International. 1997:173-223. 21. Drici M-D, Clément N. Is gender a risk factor for adverse drug reactions? Drug safety. 2001;24(8):575-85. 22. Viktil KK, Blix HS, Reikvam A, et al. Comparison of drug-related problems in different patient groups. Annals of Pharmacotherapy. 2004;38(6):942-8. 23. Ramos Linares S DRP, Mesa Fumero J, . Incidence rate of adverse drug effects in a hospital emergency unit and its associated factors. J.Farma. 2010;34(6):271-8. 24. Harduar-Morano L, Simon MR, Watkins S, et al. A population-based epidemiologic study of emergency department visits for anaphylaxis in Florida. Journal of Allergy and Clinical Immunology. 2011;128(3):594-600. 25. Malhotra S, Karan R, Pandhi P, et al. Drug related medical emergencies in the elderly: role of adverse drug reactions and non-compliance. Postgraduate Medical Journal. 2001;77(913):703-7. 26. Svarstad BL, Cleary PD, Mechanic D, et al. Gender differences in the acquisition of prescribed drugs: an epidemiological study. Medical Care. 1987;1089-98. 27. Alomar MJ. Factors affecting the development of adverse drug reactions (Review article). Saudi Pharmaceutical Journal. 2014;22(2):83-94. 28. McDowell SE, Coleman JJ, Ferner R. Systematic review and meta-analysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine. BMJ. 2006;332(7551):1177-81. 29. Egger T, Dormann H, Ahne G, et al. Cytochrome P450 Polymorphisms in Geriatric Patients. Drugs & aging. 2005;22(3):265-72. 30. Meyer UA. Pharmacogenetics and adverse drug reactions. The Lancet. 2000;356(9242):1667-71. 31. Perron BE, Bohnert AS, Monsell SE, et al. Patterns and correlates of drug-related ED visits: results from a national survey. The American Journal of Emergency medicine. 2011;29(7):704-10. 32. Lantz PM, House JS, Lepkowski JM, et al. Socioeconomic factors, health behaviors, and mortality: results from a nationally representative prospective study of US adults. JAMA. 1998;279(21):1703-8. 33. Baena MI, Faus MJ, Fajardo PC, et al. Medicine-related problems resulting in emergency department visits. European Journal of Clinical Pharmacology. 2006;62(5):387-93. 34. Cadieux R. Drug interactions in the elderly. How multiple drug use increases risk exponentially. Postgraduate Medicine. 1989;86(8):179-86. 35. Blix HS, Viktil KK, Moger TA, et al. Drugs with narrow therapeutic index as indicators in the risk management of hospitalised patients. Pharm Pr Granada. 2010;8:50-5. 36. Pedrós C, Quintana B, Rebolledo M, et al. Prevalence, risk factors and main features of adverse drug reactions leading to hospital admission. European Journal of Clinical Pharmacology. 2014;70(3):361-7. 37. Heaton PC, Tundia NL, Luder HR. US emergency departments visits resulting from poor medication adherence: 2005- 07. Journal of the American Pharmacists Association: 2012;53(5):513-9. 38. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly: an update. Archives of Internal Medicine. 1997;157(14):1531-6. 39. Budnitz DS, Lovegrove MC, Shehab N, et al. Emergency hospitalizations for adverse drug events in older Americans. New England Journal of Medicine. 2011;365(21):2002-12. 40. Perrone V, Conti V, Venegoni M, et al. seriousness, preventability, and burden impact of reported adverse drug reactions in lombardy emergency departments: a retrospective 2-year characterization. ClinicoEconomics and Outcomes Research. 2014;6:505. 41. Chang CB, Chen JH, Wen CJ, et al. Potentially inappropriate medications in geriatric outpatients with polypharmacy: application of six sets of published explicit criteria. British Journal of Clinical Pharmacology. 2011;72(3):482-9. 42. Simon SR, Smith DH, Feldstein AC, et al. Computerized prescribing alerts and group academic detailing to reduce the use of potentially inappropriate medications in older people. Journal of the American Geriatrics Society. 2006;54(6):963-8. 43. Chen Y-C, Fan J-S, Chen M-H, et al. Risk factors associated with adverse drug events among older adults in emergency department. European Journal of Internal Medicine. 2014;25(1):49-55. 44. Hohl CM, Yu E, Hunte GS, et al. Clinical decision rules to improve the detection of adverse drug events in emergency department patients. Academic Emergency Medicine. 2012;19(6):640-9. 45. Capuano A, Irpino A, Gallo M, et al. Regional surveillance of emergencydepartment visits for outpatient adverse drug events. European journal of clinical pharmacology. 2009;65(7):721-8. 46. Roulet L, Ballereau F, Hardouin J-B, et al. Assessment of adverse drug event recognition by emergency physicians in a French teaching hospital. Emergency Medicine Journal. 2013;30(1):63-7. 47. Pretorius RW, Gataric G, Swedlund SK, et al. Reducing the risk of adverse drug events in older adults. Am Fam Physician. 2013;87(5):331-6. 48. Rieger K, Scholer A, Arnet I, et al. High prevalence of unknown co-medication in hospitalised patients. European Journal of Clinical Pharmacology. 2004;60(5):363-8. 49. Ventura MT, Laddaga R, Cavallera P, et al. Adverse drug reactions as the cause of emergency department admission: focus on the elderly. Immunopharmacology and immunotoxicology. 2010;32(3):426-9. 50. Kissinger P, Cohen D, Brandon W, et al. Compliance with public sector HIV medical care. Journal of the National Medical Association. 1995;87(1):19. 51. Shea S, Misra D, Ehrlich MH, et al. Correlates of nonadherence to hypertension treatment in an inner-city minority population. American Journal of Public Health. 1992;82(12):1607-12. 52. Chen YC, Fan JS, Hsu TF, et al. Detection of patients presenting with adverse drug events in the emergency department. Internal medicine journal. 2012;42(6):651-7. 53. Segal R, Pilote L. Warfarin interaction with Matricaria chamomilla. Canadian Medical Association Journal. 2006;174(9):1281-2. 54. Nickel CH, Ruedinger JM, Messmer AS, et al. Drug-related emergency department visits by elderly patients presenting with non-specific complaints. Scand J Trauma Resusc Emerg Med. 2013;21(1):15. 55. Castro I, Guardiola JM, Tuneu L, et al. Drug-related visits to the emergency department in a Spanish university hospital. International Journal of Clinical Pharmacy. 2013;35(5):727-35.
|
| spellingShingle |
Factors Associated With Drug-Related Emergency Department Visit: A Systematic Review
|
| summary |
Drug-related hospitalization has been identified as a significant contributor to mortality, morbidity and increase in healthcare cost. This systematic review examines the factors associated with drug-related emergency department (ED) visit to better understand the factors, including the common drugs involved and people at high risk of drug-related ED visits. Relevant articles published from January 2000 to September 2015 were identified from PubMed and from a manual search of a reference list of articles. A total of 30 studies were reviewed based on the inclusion criteria. From this review, drug-related ED visit was found to be multifactorial. Many factors such as; old age, female gender, ethnicity, being socially disconnected, low health practice index, polypharmacy, comorbidity, drugs with narrow therapeutic index, drug use in management of chronic illness, drug abuse, drug intoxication, self-medication, presence of chronic illness, long-term care residents, consulting multiple prescribers and pharmacies were found to be associated with drug-related ED visit. The classes of drugs most frequently implicated were cardiovascular agents, central nervous systems (CNS) agents, anticoagulants, antimicrobials, antidiabetics, NSAIDS, antiasthmatics, corticosteroids, chemotherapeutic agents and aphrodisiacs. Preventive measures to improve patient safety should be focused towards the identified factors and the frequently implicated drugs.
|
| title |
Factors Associated With Drug-Related Emergency Department Visit: A Systematic Review
|
| title_full |
Factors Associated With Drug-Related Emergency Department Visit: A Systematic Review
|
| title_fullStr |
Factors Associated With Drug-Related Emergency Department Visit: A Systematic Review
|
| title_full_unstemmed |
Factors Associated With Drug-Related Emergency Department Visit: A Systematic Review
|
| title_short |
Factors Associated With Drug-Related Emergency Department Visit: A Systematic Review
|
| title_sort |
factors associated with drug-related emergency department visit: a systematic review
|